Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Act-Hib TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: haemophilus influenzae type b conjugate (prp-tt) vaccine
Brand name
(ARTG)
: ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
For use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the Haemophilus influenzae type b.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intramuscular
- Lyophilised vaccine: type 1 glass vial sealed with elastomer stopper and aluminium/plastic seal.
Component :
- Diluent, not applicable
- Intramuscular
- Diluent: clear colourless solution.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x single dose vaccine powder in vial and 1 x 0.5 mL diluent in pre-filled syringe with 2 separate needles pack
- 10 x single dose vaccine powder in vial and 10 x 0.5mL diluent in pre-filled syringe with 20 separate needles pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient haemophilus influenzae type b conjugate (prp-tt) vaccine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
List of nationally notifiable diseases | Australian Government Department of Health and Aged Care
This page lists diseases that states and territories have agreed to report to us through the National Notifiable Diseases Surveillance System.
Read more on Australian Government Department of Health and Aged Care website
Japanese encephalitis | NCIRS
Japanese encephalitis NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Japanese encephalitis (JE) situation in Australia has been declared a Communicable Disease Incident of National Significance as of March 2022
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Respiratory syncytial virus (RSV) FAQs | NCIRS
Respiratory syncytial virus (RSV) is a common virus that can infect people of all ages. It is most serious in infants, young children and older adults.
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Top results
